Syncom Formulations (India) Limited (BOM:524470)

Market Cap	12.97B -18.5%
Revenue (ttm)	5.03B +28.6%
Net Income	689.58M +76.2%
EPS	0.70 +75.0%
Shares Out	940.00M
PE Ratio	19.81
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	440,530
Average Volume	332,838
Open	13.75
Previous Close	13.37
Day's Range	13.57 - 13.85
52-Week Range	10.21 - 23.46
Beta	n/a
RSI	64.95
Earnings Date	May 30, 2026

About BOM:524470

Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India and internationally. It operates through Manufacturing and Dealing in Pharmaceutical Drug and Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, dry syrups and suspensions, creams, gel, ORS, jelly, gynae, inhalers, opthal, ortho, and pediatrics formulations in dosage forms. It also provides life care, evolve, an...

• Founded: 1988
• Employees: 744
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524470

Financial Performance

In fiscal year 2025, BOM:524470's revenue was 4.65 billion, an increase of 76.55% compared to the previous year's 2.63 billion. Earnings were 494.35 million, an increase of 95.28%.